PubMed Venkova, K., Mann, W., Nelson, R., & Greenwood-Van Meerveld, B
Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease
From a patient safety perspective, individuals should seek prompt medical advice if they experience: Severe or persistent abdominal pain (which may indicate pancreatitis) Right-upper-quadrant pain, fever, or jaundice (which may indicate a gallbladder problem) Rapid or irregular heartbeat Symptoms of hypoglycaemia, such as shakiness, sweating, or confusion Signs of an allergic reaction, such as rash, swelling, or difficulty breathing If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
The improved regulation of glycemia by GLP-1RA, along with their ability to reduce lipid synthesis, enhanced beta oxidation of free fatty acids and autophagy of fat cells contributes to their lipid modulation properties (59)
Potential pathways include improvements in endothelial function, reductions in blood pressure, anti-inflammatory effects, and direct myocardial protection, all of which have been described with GLP-1RA therapy independent of weight change [12,13,14]
It is still slowing gastric emptying